Caveolin: A possible biomarker of degradable metallic materials toxicity in vascular cells
Source abstract
Abstract
Iron-based materials could constitute an interesting option for cardiovascular biodegradable stent applications due to their appropriate ductility compared with their counterparts, magnesium alloys. However, the predicted degradation rate of pure iron is considered to be too slow for such applications. We explored manganese (35 wt.%) as an alloying element in combination with iron to circumvent this problem through powder metallurgical processing (Fe-35Mn). Manganese, on the other hand, is highly cytotoxic. We recently explored a new method to better characterize the safety of degradable metallic materials (DMMs) by establishing the gene expression profile (GEP) of cells (mouse 3T3 fibroblasts) exposed to Fe-35Mn degradation products in order to better understand their global response to a potentially cytotoxic DMM. We identified a number of up- and down-regulated genes and confirmed the regulation of a subset of them by quantitative real time polymerase chain reaction. Caveolin-1 (cav1), the structural protein of caveolae, small, smooth plasma membrane invaginations present in various differentiated cell types, was one of the most down-regulated genes in our GEPs. In the present study we further studied the potential of this 22 kDa protein to become a biomarker for cytotoxicity after exposure to degradable metallic elements. In order to better characterize cav1 expression in this context 3T3 mouse fibroblasts were exposed to either ferrous and manganese ions at cytostatic concentrations for 24 or 48 h. cav1 gene expression was not influenced by exposure to ferrous ions. On the other hand, exposure to manganese for 24h reduced cav1 gene expression by about 30% and by >65% after 48 h compared with control 3T3 cells. The cav1 cellular protein content was reduced to the same extent. The same pattern of expression of cav3 (the muscle-specific caveolin subtype) was also observed in this study. This strong and reproducible pattern of regulation of caveolins thus indicates potential as a biomarker for the toxicity of DMM elements.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Caveolin-1 and cellular processes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (28)
Show source-provided references
1. Transcytosis of a1-acidic glycoprotein in the continuous microvascular endothelium10.1073/pnas.95.11.6175 ↗
2. The caveolae membrane system10.1146/annurev.biochem.67.1.199 ↗
3. Role of plasmalemmal caveolae in signal transduction
4. Caveolin-3 upregulation activates b-secretase-mediated cleavage of the amyloid precursor protein in Alzheimer’s disease10.1523/JNEUROSCI.19-15-06538.1999 ↗
5. Characterisation of caveolins from cartilage: expression of caveolin-1, -2, and -3 in chondrocytes and in alginate cell culture of the rat tibia10.1007/s004180050390 ↗
6. Caveolins, a family of scaffolding proteins for organizing ‘preassembled signaling complexes’ at the plasma membrane10.1074/jbc.273.10.5419 ↗
7. Biomarkers of drug-induced vascular injury10.1016/j.taap.2005.04.028 ↗
8. Identification of caveolin-1 as a fatty acid binding protein10.1006/bbrc.1998.0123 ↗
9. Purnama A, Hermawan H, Champetier S, Mantovani D, Couet J. Gene expression profile of mouse fibroblasts exposed to a biodegradable iron alloy for stents. Acta Biomater, 2013 http://dx.doi.org/10.1016/j.actbio.2013.02.03310.1016/j.actbio.2013.02.033 ↗
10. Assessing the biocompatibility of degradable metallic materials: state-of-the-art and focus on the potential of genetic regulation10.1016/j.actbio.2010.02.027 ↗
11. Regulation of caveolin-1 expression, nitric oxide production and tissue injury by tumor necrosis factor-a following ozone inhalation10.1016/j.taap.2007.11.012 ↗
12. Gene profiling of left ventricle eccentric hypertrophy in aortic regurgitation in rats: rationale for targeting the beta-adrenergic and renin–angiotensin systems10.1152/ajpheart.01046.2008 ↗
13. Analysis of relative gene expression data using real-time quantitative PCR and the 2[−delta delta C(T)] method10.1006/meth.2001.1262 ↗
14. Fe–Mn alloys for metallic biodegradable stents: degradation and cell viability studies10.1016/j.actbio.2009.11.025 ↗
15. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol10.1073/pnas.94.20.10693 ↗
16. Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue10.1016/j.ygyno.2005.04.034 ↗
17. Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 activates beta-catenin and c-Myc, and down-regulates caveolin-1
18. Direct control of caveolin-1 expression by FOXO transcription factors10.1042/BJ20041449 ↗
19. Role of NF-κB dependent caveolin-1 expression in the menchanism of increased endothelial permeability induced by LPS10.1074/jbc.M703153200 ↗
20. Miao JY The effect of novel magnetic nanoparticles on vascular endothelial cell function in vitro and in vivo10.1016/j.jhazmat.2012.08.003 ↗
21. Promotion of autophagy and inhibition of apoptosis by low concentrations of cadmium in vascular endothelial cells10.1016/j.tiv.2008.11.003 ↗
22. Up-regulation of caveolin expression by cytotoxic agents in drug-sensitive cancer cells10.1097/00001813-200304000-00005 ↗
23. Role of caveolin-1 in etoposide resistance development in A549 lung cancer cells10.4161/cbt.3.10.1112 ↗
24. G2/M blockade by paclitaxel induces caveolin-1 expression in A549 lung cancer cells: caveolin-1 as a marker of cytotoxicity10.1097/00001813-200411000-00005 ↗
25. Reduction of caveolin-1 gene expression in lung cancer cell lines10.1006/bbrc.1999.0236 ↗
26. Molecular and cellular biology of caveolae: paradoxes and plasticities10.1016/S1050-1738(97)00001-7 ↗
27. Cell biology of caveolae and caveolin10.1016/S0169-409X(01)00139-9 ↗
28. Altered caveolin-3 expression disrupts PI(3) kinase signaling leading to death of cultured muscle cells10.1016/j.yexcr.2006.05.010 ↗